115 related articles for article (PubMed ID: 12646970)
21. Delayed Gadolinium-enhanced MR Imaging of Cartilage: A Comparative Analysis of Different Gadolinium-based Contrast Agents in an ex Vivo Porcine Model.
Kang Y; Choi JY; Yoo HJ; Hong SH; Kang HS
Radiology; 2017 Mar; 282(3):734-742. PubMed ID: 27649101
[TBL] [Abstract][Full Text] [Related]
22. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
Sato T; Ito K; Tamada T; Kanki A; Watanabe S; Nishimura H; Tanimoto D; Higashi H; Yamamoto A
Magn Reson Imaging; 2013 Oct; 31(8):1412-7. PubMed ID: 23643157
[TBL] [Abstract][Full Text] [Related]
23. AN69-ST membrane, a useful option in two cases of severe dialysis reactions.
Cerqueira A; Martins PA; Carvalho BA; Vasconcelos MP
Clin Nephrol; 2015 Feb; 83(2):100-3. PubMed ID: 25208312
[TBL] [Abstract][Full Text] [Related]
24. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
Joy MS; Matzke GR; Frye RF; Palevsky PM
Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
[TBL] [Abstract][Full Text] [Related]
25. Extracellular gadolinium contrast agents: differences in stability.
Morcos SK
Eur J Radiol; 2008 May; 66(2):175-9. PubMed ID: 18343072
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
[TBL] [Abstract][Full Text] [Related]
27. Permeability of contrast media through hemodialysis membrane.
Furukawa T; Ueda J; Higashino K; Takahashi S; Sakaguchi K; Imai T
Acta Radiol; 1997 Sep; 38(5):918-21. PubMed ID: 9332256
[TBL] [Abstract][Full Text] [Related]
28. High molecular weight kininogen adsorption on hemodialysis membranes: influence of pH and relationship with contact phase activation of blood plasma. influence of pre-treatment with poly(ethyleneimine).
Thomas M; Valette P; Mausset AL; Déjardin P
Int J Artif Organs; 2000 Jan; 23(1):20-6. PubMed ID: 12118833
[TBL] [Abstract][Full Text] [Related]
29. Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function.
Matzkies FK; Reinecke H; Tombach B; Kosch M; Hegger K; Milius M; Hohage H; Kisters K; Kerber S; Schaefer RM
Am J Nephrol; 2000; 20(4):300-4. PubMed ID: 10970983
[TBL] [Abstract][Full Text] [Related]
30. Kinetics of 131I-beta2 microglobulin in hemodialysis patients: assessment using total body counting.
Chanard J; Caudwell V; Valeire J; Vincent C; Randoux C; Wuillai A; Wynckel A
Artif Organs; 1998 Jul; 22(7):574-80. PubMed ID: 9684694
[TBL] [Abstract][Full Text] [Related]
31. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
32. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L
Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845
[TBL] [Abstract][Full Text] [Related]
33. Acute kidney injury: effect of hemodialysis membrane on Hgf and recovery of renal function.
Libetta C; Esposito P; Sepe V; Rampino T; Zucchi M; Canevari M; Dal Canton A
Clin Biochem; 2013 Jan; 46(1-2):103-8. PubMed ID: 23099196
[TBL] [Abstract][Full Text] [Related]
34. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.
Lornoy W; Becaus I; Billiouw JM; Sierens L; Van Malderen P; D'Haenens P
Nephrol Dial Transplant; 2000; 15 Suppl 1():49-54. PubMed ID: 10737167
[TBL] [Abstract][Full Text] [Related]
35. Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes.
Verresen L; Fink E; Lemke HD; Vanrenterghem Y
Kidney Int; 1994 May; 45(5):1497-503. PubMed ID: 8072263
[TBL] [Abstract][Full Text] [Related]
36. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
Balducci A; Coen G; Manni M; Perruzza I; Fassino V; Sardella D; Grandi F
Artif Organs; 2004 Dec; 28(12):1067-75. PubMed ID: 15554934
[TBL] [Abstract][Full Text] [Related]
37. Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro study.
Manley HJ; Grabe DW
BMC Nephrol; 2004 Jan; 5():1. PubMed ID: 14718064
[TBL] [Abstract][Full Text] [Related]
38. Reaction of gadolinium chelates with endogenously available ions.
Tweedle MF; Hagan JJ; Kumar K; Mantha S; Chang CA
Magn Reson Imaging; 1991; 9(3):409-15. PubMed ID: 1881260
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
[TBL] [Abstract][Full Text] [Related]
40. Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes.
Sirolli V; Ballone E; Amoroso L; Di Liberato L; Di Mascio R; Capelli P; Albertazzi A; Bonomini M
Int J Artif Organs; 1999 Aug; 22(8):536-42. PubMed ID: 10533909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]